Price
Target price
€15.45
€15.45
-1.590%
-0.25
-1.590%
€22.04
22:26 / Tradegate
WKN: 883035 / Symbol: TEVA / Name: Teva Pharma / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Teva Pharmaceutical Industries Ltd ADR Stock
A loss of -1.590% shows a downward development for Teva Pharmaceutical Industries Ltd ADR.
Teva Pharmaceutical Industries Ltd ADR is currently one of the favorites of our community with 17 Buy predictions and no Sell predictions.
As a result the target price of 22 € shows a positive potential of 42.39% compared to the current price of 15.45 € for Teva Pharmaceutical Industries Ltd ADR.
For the coming years our community has positive and negative things to say abot the Teva Pharmaceutical Industries Ltd ADR stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Conscious of the environment" there were negative voices in the community.
Pros and Cons of Teva Pharmaceutical Industries Ltd ADR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Teva Pharmaceutical Industries Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | -1.590% | 4.305% | 4.651% | 0.962% | -26.744% | 97.368% | 41.382% |
| Bayer AG ADR | -0.740% | 5.426% | 20.354% | 1.493% | 37.097% | -58.025% | -59.036% |
| Roche Holding AG ADR | -0.480% | 0.783% | 5.218% | 15.297% | 7.622% | -5.614% | -6.862% |
| Astrazeneca ADR | -1.550% | 2.381% | 6.612% | -13.423% | 0.781% | 8.953% | - |
Comments
Teva Pharmaceutical Industries Limited (NYSE: TEVA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $24.00 price target on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $25.00 price target on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $23.00 price target on the stock, up previously from $21.00.
Show more
Ratings data for TEVA provided by MarketBeat
News
Teva Pharmaceutical Stock: Strategic Global Access Initiatives Advance
Teva Pharmaceutical Industries Ltd. continues to strengthen its global market position through strategic access initiatives for essential medications. The company has made significant progress
Teva Pharmaceutical Stock: European Generic Drug Market Faces Consolidation
A recent study by Teva Pharmaceuticals Europe reveals concerning trends in the European pharmaceutical landscape, highlighting significant market consolidation in critical generic medications. The